Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.
Newly-launched obesity company Kailera Therapeutics has announced the appointment of Jamie Coleman as chief commercial ...
Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the ...
You can’t ruin my destiny, Peyton. Not this time, I’m 44 now!” Eli Manning exclaims in FanDuel’s Super Bowl promo.
Hosted on MSN14h
Amgen price target lowered to $295 from $310 at CitiCiti lowered the firm’s price target on Amgen (AMGN) to $295 from $310 and keeps a Neutral rating on the shares. Ahead of the ...
Could Eli Lilly’s Stock Struggles Reveal a Deeper Issue?
Sabrina Ionescu and Randy Moss spoke exclusively to PEOPLE on set of their Michelob Ultra Super Bowl ad where the NFL icon ...
Citi analyst Geoff Meacham lowered the firm’s price target on Eli Lilly to $1,190 from $1,250 and keeps a Buy rating on the shares. Ahead of ...
Citi raised the firm’s price target on Bristol Myers (BMY) to $65 from $60 and keeps a Neutral rating on the shares. Ahead of the Q4 earnings, ...
Apogee Therapeutics develops therapies for inflammatory autoimmune diseases. Find out why I'm bearish on APGE stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback